Andreas Leibbrandt
- Immunology top 5%
- interferon and immune responses 1
- Oncology top 5%
- Bone health and treatments 6
- Cytokine Signaling Pathways and Interactions 3
- Cancer Research top 5%
- NF-κB Signaling Pathways 4
- Molecular Biology top 10%
- Bone Metabolism and Diseases 7
-
- Antimicrobial Peptides and Activities 2
-
- Fungal Biology and Applications 2
-
- Influenza Virus Research Studies 1
- Co-authors
- Josef PenningerAnnette NeubüserJohannes WerzowaFrank EisenhaberMaria NovatchkovaJ. Andrew PospisilikDaniel SchramekWilliam E. Jenkinson
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- AustriaGermanyUnited Kingdom
In The Last Decade
Andreas Leibbrandt
19 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 102
- Immunology 740
- Oncology 691
- Cancer Research 315
- Molecular Biology 981
- Orthopedics and Sports Medicine 122
Countries citing papers authored by Andreas Leibbrandt
This map shows the geographic impact of Andreas Leibbrandt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Leibbrandt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Leibbrandt more than expected).
Fields of papers citing papers by Andreas Leibbrandt
This network shows the impact of papers produced by Andreas Leibbrandt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Leibbrandt. The network helps show where Andreas Leibbrandt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andreas Leibbrandt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 1 | |
| 2 | 2010 | 152 | |
| 3 | 2010 | 423 | |
| 4 | 2010 | 7 | |
| 5 | 2009 | 245 | |
| 6 | 2009 | 8 | |
| 7 | 2009 | 1 | |
| 8 | 2009 | 35 | |
| 9 | 2009 | 30 | |
| 10 | 2009 | 42 | |
| 11 | 2008 | 10 | |
| 12 | 2008 | 316 | |
| 13 | 2007 | 68 | |
| 14 | 2007 | 8 | |
| 15 | 2007 | 379 | |
| 16 | 2004 | 33 | |
| 17 | 2003 | 217 | |
| 18 | 2003 | 39 | |
| 19 | 1998 | 88 |
About Andreas Leibbrandt
Andreas Leibbrandt is a scholar working on Microbiology, Cancer Research and Oncology, having authored 19 papers that have together received 2.1k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (7 papers), Bone health and treatments (6 papers), NF-κB Signaling Pathways (4 papers), Cytokine Signaling Pathways and Interactions (3 papers), Antimicrobial Peptides and Activities (2 papers), Fungal Biology and Applications (2 papers), interferon and immune responses (1 paper) and Influenza Virus Research Studies (1 paper). The work is most often cited by research in Immunology (740 citations), Oncology (691 citations) and Cancer Research (315 citations). Andreas Leibbrandt has collaborated with scholars based in Austria, Germany and United Kingdom. Frequent co-authors include Josef Penninger, Annette Neubüser, Johannes Werzowa, Frank Eisenhaber, Maria Novatchkova, J. Andrew Pospisilik, Daniel Schramek, William E. Jenkinson, Graham Anderson and Peter J. L. Lane. Their work appears in journals such as Nature, Science and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.